← All trials
NCT06396416
Phase 4Interventional
Studies of FDA-approved drugs to delineate additional information including the drug's risks, benefits, and optimal use.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Sep 26, 2024
- Primary completion
- Dec 31, 2025
- Completion date
- Dec 31, 2025
- First posted
- May 2, 2024
- Last posted
- Oct 2, 2024
- Enrollment
- 60
- Arms / groups
- 2 / —
- Source
- AACT · ctgov ingestion
Sponsors
- University of Western OntarioLead sponsor
- University of AdelaideCollaborator
- University of Western OntarioSponsor investigator
- University of Western OntarioCollaborator
- University of Western OntarioOfficial
- University of Western OntarioOfficial
- London Health Sciences CentreCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.